Baxter International (BAX) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Baxter International · Health Care · ref. ETF XLV · 50 calls · price $24.89
What the company does: Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products.
📈 Baxter International (BAX) stock price
$24.89+9.1% over range
Oct 14, 25low $15.8 · high $28.35Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
13% recommend buying · 8 analysts
📊 JPI status : Baxter International has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 BAX price target & analyst consensus — price $24.89
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$29+16.5%
Median target · of 8 targets$24.5-1.6%
Lowest target · 1 firm of 8$20-19.6%
Current price$24.89
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
450%
$25 ↔ $29
Below
450%
$20 ↔ $24
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Stifel — 68% of its targets hit on this sector (304 calls tested). It aims for $28 (+13 %), call made on August 1, 2026, maturing on August 1, 2027 (74 d ago).
The 6 reliable analysts
$26+4.5 %
The 2 other firms
$22.50-9.6 %
How to read it: the 6 reliable firms are not filtered by optimism — 4 aim above the price, 2 below, hence their $26 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy113%
Hold675%
Sell113%
Strong Sell00%
Go deeper on the analysts
🎯 BAX price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on BAX most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BAX? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Baxter International? The JPI assistant answers using our backtest data.
💰 Baxter International dividend: yield, history & growth › open the full page
0.92%annual yield
That's ~$0.20 per share per year.
📈 Baxter International fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -9.3 %Revenue growth +5.3 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -16 %
2023
Rev −2%
2024
Rev −28%Profit −124%
2025
Rev +6%
🔎 Detailed analyses
🏛️ Which US Congress members hold Baxter International (BAX)?
3 Congress members have disclosed BAX buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on BAX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| BMO Capital ↗ | 100% | +18.0% | 5 |
| Piper Sandler ↗ | 100% | +14.1% | 4 |
| Goldman Sachs ↗ | 88% | +19.6% | 8 |
| UBS ↗ | 83% | +11.2% | 6 |
| Deutsche Bank ↗ | 67% | +18.1% | 3 |
| Wells Fargo ↗ | 62% | +3.2% | 8 |
| B of A Securities ↗ | 60% | -2.3% | 5 |
| Credit Suisse | 56% | +4.8% | 9 |
| Citigroup ↗ | 50% | -6.6% | 4 |
| Barclays ↗ | 45% | -4.8% | 20 |
See the other 7 firms
| Cowen & Co. | 0% | -14.7% | 2 |
| Keybanc ↗ | 8% | -20.3% | 12 |
| Raymond James ↗ | 17% | -14.5% | 12 |
| Stifel ↗ | 33% | -17.3% | 6 |
| JP Morgan ↗ | 43% | -2.0% | 7 |
| Evercore ISI Group ↗ | 43% | -1.6% | 7 |
| Morgan Stanley ↗ | 44% | -8.9% | 18 |
📊 What $1,000 invested in Baxter International would be worth › open the full page
In short — $1,000 invested in Baxter International 10 years ago would be worth $559 today, i.e. -6%/yr on average. Best year: 2017 (+46%), worst: 2022 (-41%). Price performance, excluding dividends.
If I'd invested $1,000 in Baxter International
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $731 | -27% |
| 3 years ago | $418 | -58% |
| 5 years ago | $266 | -73% |
Return by year (Baxter International)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +12% | $1,116 (+12%) |
| 2025 | -34% | $731 (-27%) |
| 2024 | -25% | $551 (-45%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Baxter International
Loading news…
📋 All analyst calls on BAX
Filtered on — · ✕ show all
▼ Underweight · 🎯$20
Price at call : $23.97 — upside -17%
Today : $24.89 — upside -20%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
■ Neutral neutral · not a buy · 🎯$27
Price at call : $24.36 — gap to target +11%
Today : $24.89 — gap to target +8%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Oct 5, 27
matures : Oct 5, 27
■ Hold neutral · not a buy · 🎯$29
Price at call : $28.1 — gap to target +3%
Today : $24.89 — gap to target +17%
🎯 on BAX : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Wells Fargo ↗
Jul 31, 26
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $28.1 — gap to target -18%
Today : $24.89 — gap to target -8%
🎯 on BAX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Hold neutral · not a buy · 🎯$28
Price at call : $28.1 — gap to target -0%
Today : $24.89 — gap to target +12%
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Neutral neutral · not a buy · 🎯$28
Price at call : $26.16 — gap to target +7%
Today : $24.89 — gap to target +12%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Neutral neutral · not a buy · 🎯$25
Price at call : $24.77 — gap to target +1%
Today : $24.89 — gap to target +0%
🎯 on BAX : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.77 — gap to target -3%
Today : $24.89 — gap to target -4%
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
See the other 42 calls, newest to oldest
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.37 — gap to target -2%
Today : $24.89 — gap to target -4%
🎯 on BAX : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Goldman Sachs ↗
Jul 15, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $23.35 — gap to target -10%
Today : $24.89 — gap to target -16%
🎯 on BAX : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$24
Price at call : $22.86 — upside +5%
Today : $24.89 — upside -4%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▼ Sell · 🎯$17
Price at call : $18.78 — upside -9%
Today : $24.89 — upside -32%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Overweight · 🎯$27
Price at call : $16.75 — upside +61%
Today : $24.89 — upside +8%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$22
Price at call : $16.62 — upside +32%
Today : $24.89 — upside -12%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
■ Neutral neutral · not a buy · 🎯$19
Price at call : $18.01 — gap to target +5%
Today : $24.89 — gap to target -24%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
Goldman Sachs ↗
Feb 17, 26
■ Neutral neutral · not a buy · 🎯$17
Price at call : $21.87 — gap to target -22%
Today : $24.89 — gap to target -32%
🎯 on BAX : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
▲ Overweight · 🎯$25
Price at call : $20.74 — upside +21%
Today : $24.89 — upside +0%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▲ Overweight · 🎯$30
Price at call : $20.15 — upside +49%
Today : $24.89 — upside +21%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
Morgan Stanley ↗
Dec 2, 25
▼ Underweight · 🎯$15
Price at call : $18.89 — upside -21%
Today : $24.89 — upside -40%
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $18.21 — gap to target +15%
Today : $24.89 — gap to target -16%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Goldman Sachs ↗
Oct 31, 25
■ Neutral neutral · not a buy · 🎯$22
Price at call : $18.21 — gap to target +21%
Today : $24.89 — gap to target -12%
🎯 on BAX : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $18.21 — gap to target +15%
Today : $24.89 — gap to target -16%
🎯 on BAX : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Argus Research ↗
Oct 31, 25
■ Hold neutral · not a buy
🎯 on BAX : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$31
Price at call : $22.75 — upside +36%
Today : $24.89 — upside +25%
Expected +36% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+5.1%
stock +5% · XLV +16%
matured Oct 7, 26
▲ Overweight · 🎯$36
Price at call : $22.84 — upside +58%
Today : $24.89 — upside +45%
Expected +58% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+19.7%
stock +20% · XLV +24%
matured Aug 4, 26
■ Hold neutral · not a buy · 🎯$25
Price at call : $22.84 — gap to target +9%
Today : $24.89 — gap to target +0%
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $22.84 — gap to target +5%
Today : $24.89 — gap to target -4%
🎯 on BAX : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
Wells Fargo ↗
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $22.44 — gap to target +7%
Today : $24.89 — gap to target -4%
🎯 on BAX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 1, 26
matures : Aug 1, 26
Morgan Stanley ↗
Jul 15, 25
▼ Underweight · 🎯$27
Price at call : $28.25 — upside -4%
Today : $24.89 — upside +8%
Expected -4% · Actual -22% · Reason (≤ −15%) : ✓ Yes
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+21.6%
stock -22% · XLV +19%
matured Jul 15, 26
■ Neutral neutral · not a buy · 🎯$32
Price at call : $29.7 — gap to target +8%
Today : $24.89 — gap to target +29%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jul 9, 26
matures : Jul 9, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$42
Price at call : $30.66 — upside +37%
Today : $24.89 — upside +69%
Expected +37% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-28.3%
stock -28% · XLV +20%
matured Jul 8, 26
Morgan Stanley ↗
May 5, 25
▼ Underweight · 🎯$28
Price at call : $29.93 — upside -6%
Today : $24.89 — upside +12%
Expected -6% · Actual -43% · Reason (≤ −15%) : ✓ Yes
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+43.3%
stock -43% · XLV +8%
matured May 5, 26
Wells Fargo ↗
May 2, 25
■ Equal-Weight neutral · not a buy · 🎯$33
Price at call : $30.43 — gap to target +8%
Today : $24.89 — gap to target +33%
🎯 on BAX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 2, 26
matures : May 2, 26
▲ Overweight · 🎯$41
Price at call : $36.56 — upside +12%
Today : $24.89 — upside +65%
Expected +12% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-52.2%
stock -52% · XLV +4%
matured Mar 10, 26
■ Neutral neutral · not a buy · 🎯$36
Price at call : $35.08 — gap to target +3%
Today : $24.89 — gap to target +45%
🎯 on BAX : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 21, 26
matures : Feb 21, 26
■ Neutral neutral · not a buy · 🎯$35
Price at call : $30.84 — gap to target +13%
Today : $24.89 — gap to target +41%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Dec 11, 25
matures : Dec 11, 25
▲ Buy · 🎯$38
Price at call : $33.83 — upside +12%
Today : $24.89 — upside +53%
Expected +12% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 50.7% · +7.8% (304 calls)
-44.7%
stock -45% · XLV +4%
matured Nov 11, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $35.97 — gap to target +11%
Today : $24.89 — gap to target +61%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Oct 1, 25
matures : Oct 1, 25
Goldman Sachs ↗
Aug 8, 24
■ Neutral neutral · not a buy · 🎯$40
Price at call : $37.15 — gap to target +8%
Today : $24.89 — gap to target +61%
🎯 on BAX : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Aug 8, 25
matures : Aug 8, 25
■ Neutral neutral · not a buy · 🎯$42
Price at call : $37.42 — gap to target +12%
Today : $24.89 — gap to target +69%
🎯 on BAX : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 7, 25
matures : Aug 7, 25
Wells Fargo ↗
Aug 7, 24
■ Equal-Weight neutral · not a buy · 🎯$40
Price at call : $37.42 — gap to target +7%
Today : $24.89 — gap to target +61%
🎯 on BAX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 7, 25
matures : Aug 7, 25
Morgan Stanley ↗
Jul 15, 24
▼ Underweight · 🎯$30
Price at call : $33.97 — upside -12%
Today : $24.89 — upside +21%
Expected -12% · Actual -17% · Reason (≤ −15%) : ✓ Yes
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+16.8%
stock -17% · XLV -10%
matured Jul 15, 25
■ Neutral neutral · not a buy · 🎯$37
Price at call : $35.22 — gap to target +5%
Today : $24.89 — gap to target +49%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jul 11, 25
matures : Jul 11, 25
Evercore ISI Group ↗
Jul 2, 24
▲ Outperform · 🎯$45
Price at call : $33.16 — upside +36%
Today : $24.89 — upside +81%
Expected +36% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-6.5%
stock -6% · XLV -5%
matured Jul 2, 25
Goldman Sachs ↗
May 30, 24
■ Neutral neutral · not a buy · 🎯$36
Price at call : $33.43 — gap to target +8%
Today : $24.89 — gap to target +45%
🎯 on BAX : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : May 30, 25
matures : May 30, 25
■ Neutral neutral · not a buy · 🎯$38
Price at call : $34 — gap to target +12%
Today : $24.89 — gap to target +53%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 22, 25
matures : May 22, 25
■ Hold neutral · not a buy · 🎯$40
Price at call : $35.69 — gap to target +12%
Today : $24.89 — gap to target +61%
🎯 on BAX : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 10, 25
matures : May 10, 25
■ Neutral neutral · not a buy · 🎯$44
Price at call : $42.63 — gap to target +3%
Today : $24.89 — gap to target +77%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Apr 3, 25
matures : Apr 3, 25
B of A Securities ↗
Mar 5, 24
■ Neutral neutral · not a buy · 🎯$45
Price at call : $42.99 — gap to target +5%
Today : $24.89 — gap to target +81%
🎯 on BAX : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Mar 5, 25
matures : Mar 5, 25
Frequently asked questions
Should I buy Baxter International stock?
This isn't buy advice. For Baxter International, the analyst consensus is "Hold", with an average price target of $24.50 (-2% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Baxter International). We show the numbers — you decide.
Is it too late to buy Baxter International? How high can it go?
The most bullish analyst target on Baxter International is $29.00 (+17% above today's price); the average is $24.50. That's the upside they see. Check how reliable those analysts have actually been on Baxter International on our site before trusting it.
Is Baxter International still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Baxter International, the best hitting 100% over 5 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Baxter International? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BAX (and why hesitate).
What has Baxter International's past performance been?
Historical returns and a "how much if I had invested" calculator: BAX performance & returns.
Does Baxter International pay a dividend?
Yield, consistency and growth history of the dividend: BAX's dividend.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX